medpagetoday news

The Effects of Diet on Multiple Myeloma: An Update

These researchers recently reviewed evidence related to the impact of dietary and other lifestyle interventions on the gut microbiome and on multiple myeloma incidence, outcomes, and patients’ quality of life.

Long-Term Myeloma Survivors: Patient-Reported Outcomes After AHCT

Physical outcomes are no worse than in general population, but distress is prevalent due to health burden, uncertainty and finances.

When Should Allogeneic HCT Recipients Receive SARS-CoV-2 Vaccination?

Using data from 22 centers, US researchers determined the optimal timing for initiation of SARS-CoV-2 vaccination in patients who have received allogeneic hematopoietic stem cell transplants.

Predicting VTE Risk in Multiple Myeloma Patients

In an analysis of three risk scores for venous thromboembolism in a cohort of 131 adults with multiple myeloma, one score stood out for its accuracy.

In Multiple Myeloma, Increased Survival Rates Seen After Some Vaccinations

Researchers uncovered lower infection-related mortality in patients with MM who were routinely vaccinated, but racial and health system disparities affected overall numbers and varied by geographical regions.
medpagetoday news

Twice as Many African Americans as Whites have Multiple Myeloma. Why are They Underrepresented in Clinical Trials?

These investigators focused on the narrowness of study criteria as a potential barrier to study inclusion.

Diagnosing Multiple Myeloma During the COVID-19 Era

Researchers in the U.K. examined two cohorts of multiple myeloma patients: those diagnosed before the onset of the pandemic and those diagnosed during it. Here’s what the data revealed.